Advertisement · 728 × 90
#
Hashtag
#EditorsPicks
Advertisement · 728 × 90
Preview
Glycaemic, appetite and circadian benefits of a dairy-enriched diet with high-protein breakfast and early daytime-restricted carbohydrate intake in type 2 diabetes: a randomised crossover trial - Diab... Aims/hypothesis The circadian timing of food intake and the composition of dietary protein sources may jointly influence metabolic regulation. Our aim was to examine the effects of a dairy-enriched vs...

Up front and free to read in our April issue #editorspicks: Glycaemic, appetite and circadian benefits of a dairy‑enriched diet with high‑protein breakfast and early daytime‑restricted carbohydrate intake in type 2 diabetes link.springer.com/article/10.1...

0 0 0 0
Preview
Islet amyloid disrupts MHC class II antigen presentation and delays autoimmune diabetes in NOD mice - Diabetologia Aims/hypothesis Islet amyloid contributes to beta cell failure in type 2 diabetes through several mechanisms, one being the potent induction of local islet inflammation through activating inflammatory...

Up front and free to read in our April issue #editorspicks: Islet amyloid disrupts MHC class II antigen presentation and delays autoimmune diabetes in NOD mice doi.org/10.1007/s001...

0 0 0 1
Preview
Effects of combined intraduodenal administration of lauric acid and l-tryptophan on postprandial plasma glucose, glucoregulatory hormones and gastric emptying in type 2 diabetes: a double-blind, rando... Aims/hypothesis In healthy men, lauric acid (C12) and l-tryptophan (Trp), when administered intraduodenally in loads of 1.26 and 0.42 kJ/min (0.3 and 0.1 kcal/min), respectively, that are individually...

Up front and free to read in our April issue #editorspicks: Effects of combined intraduodenal administration of lauric acid andl‑tryptophan on postprandial plasma glucose, glucoregulatory hormones and gastric emptying in type 2 diabetes doi.org/10.1007/s001...

0 0 0 0
Preview
The evolving understanding of cystic fibrosis-related diabetes in the highly effective modulator therapy era: a scoping review - Diabetologia Cystic fibrosis-related diabetes (CFRD) is a unique form of diabetes that shares features with both type 1 and type 2 diabetes and is most often characterised by transient postprandial hyperglycaemia ...

Up front and free to read in our April issue #editorspicks: The evolving understanding of cystic fibrosis-related diabetes in the highly effective modulator therapy era: a scoping review doi.org/10.1007/s001...

2 1 0 0
Preview
Sex steroids, SHBG and type 2 diabetes in women: what do we really know? - Diabetologia Androgens and oestrogens differentially regulate metabolic processes that impact the development of type 2 diabetes in women. The biological actions of these sex steroids are, however, dependent on th...

Up front and free to read in our April issue #editorspicks: Sex steroids, SHBG and type 2 diabetes in women: what do we really know? doi.org/10.1007/s001...

3 1 0 0
Image of ten book covers under the title "Editors' Picks" with the "Choice" logo below.

Image of ten book covers under the title "Editors' Picks" with the "Choice" logo below.

Ten reviews handpicked by the Choice editors from the recent issue of Choice Magazine. These #EditorsPicks stand out for their excellence, timeliness, originality, or sheer reading pleasure.
ow.ly/fyv350YzSaU
#Academic #Publishing #BookReview

2 0 1 0
Preview
Ketone supplementation dose-dependently lowers postprandial blood glucose, lipid and ghrelin levels in individuals with type 2 diabetes: a randomised crossover study - Diabetologia Aims/hypothesis Postprandial hyperglycaemia and hyperlipidaemia are independent risk factors for CVD in individuals with type 2 diabetes. We aimed to test whether a ketone monoester (KE) and ketone sa...

Up front & free to read in our March issue #editorspicks: Ketone supplementation dose‑dependently lowers postprandial blood glucose, lipid and ghrelin levels in individuals with type 2 diabetes: a randomised crossover study doi.org/10.1007/s001...

3 1 1 0
Preview
MNX1 prevents somatostatin expression in human beta cells by repressing PERCC1 - Diabetologia Aims/hypothesis A highly specific mosaic transcriptional environment guides the fate of pancreatic progenitors during development and maintains the identity of mature endocrine cells. In mice, one suc...

Up front & free to read in our March issue #editorspicks: MNX1 prevents somatostatin expression in human beta cells by repressing PERCC1 doi.org/10.1007/s001...

2 1 0 0

Up front in the March issue of @diabetologiajnl.bsky.social #editorspicks #diabetesresearch

1 0 0 0

Up front in the March issue of @diabetologiajnl.bsky.social #editorspicks #diabetesresearch

1 0 0 0
Preview
Impact of cardiovascular autonomic neuropathy on cardiopulmonary, sympathoadrenal and metabolic responses to physical exercise in adults with type 1 diabetes - Diabetologia Aims/hypothesis The aim of this work was to compare the cardiopulmonary, sympathoadrenal and metabolic responses to physical exercise in adults with type 1 diabetes with or without cardiovascular auto...

Up front & free to read in our March issue #editorspicks: Impact of cardiovascular autonomic neuropathy on cardiopulmonary, sympathoadrenal and metabolic responses to physical exercise in adults with type 1 diabetes doi.org/10.1007/s001...

3 1 0 1
Preview
Fully closed-loop systems: can people with type 1 diabetes just do it? Insights from open-source systems - Diabetologia Automated insulin delivery (AID) systems have significantly advanced diabetes management, progressively reducing user interactions required for optimal glucose management. This review evaluates the cu...

Up front & free to read in our March issue #editorspicks: Fully closed‑loop systems: can people with type 1 diabetes just do it? Insights from open‑source systems doi.org/10.1007/s001...

3 0 0 1

Up front in the March issue of Diabetologia #EditorsPicks #DiabetesResearch

0 0 0 0
Preview
Improving medication adherence in type 2 diabetes: strategies for better clinical and economic outcomes - Diabetologia Medication adherence is critical for optimal glycaemic management and the prevention of complications in type 2 diabetes mellitus. Despite its importance, non-adherence remains a prevalent issue, with...

Up front & free to read in our March issue #editorspicks: Improving medication adherence in type 2 diabetes: strategies for better clinical and economic outcomes doi.org/10.1007/s001...

4 0 0 1
A display of nine book covers titled "Editors' Picks" with the "Choice" logo below.

A display of nine book covers titled "Editors' Picks" with the "Choice" logo below.

Nine reviews handpicked by the Choice editors from a recent issue of Choice Magazine. These #EditorsPicks stand out for their excellence, timeliness, originality, or sheer reading pleasure.
ow.ly/9rbu50YoJb9
#Academic #Publishing #BookReview

20 3 0 0
Preview
Precision medicine in type 2 diabetes: targeting SGLT2 inhibitor treatment for kidney protection - Diabetologia Aims/hypothesis Current guidelines recommend use of sodium–glucose cotransporter-2 inhibitors (SGLT2 inhibitors) for kidney protection in people with type 2 diabetes and early-stage chronic kidney dis...

Up front & free to read in our Feb issue #editorspicks: Precision medicine in type 2 diabetes: targeting SGLT2 inhibitor treatment for kidney protection doi.org/10.1007/s001...

2 1 0 0
Preview
Safety and pharmacokinetics of teplizumab in children less than 8 years of age with stage 2 type 1 diabetes - Diabetologia Aims/hypothesis Teplizumab is approved in the USA and seven other countries to delay stage 3 type 1 diabetes onset in individuals ≥8 years of age with stage 2 type 1 diabetes. As part of a US Food and...

Up front & free to read in our Feb issue #editorspicks: Safety and pharmacokinetics of teplizumab in children less than 8 years of age with stage 2 type 1 diabetes doi.org/10.1007/s001...

2 1 0 0
Preview
Effectiveness of video consultations in type 1 diabetes patients treated with insulin pumps in the outpatient clinic: a randomised controlled trial - Diabetologia Aims/hypothesis The aim of this work was to assess the effect of video consultations over 1 year compared with usual care for patients with type 1 diabetes treated with insulin pumps, with time in ran...

Up front & free to read in our Feb issue #editorspicks: Effectiveness of video consultations in type 1 diabetes patients treated with insulin pumps in the outpatient clinic: a randomised controlled trial doi.org/10.1007/s001...

2 0 0 0
Preview
Comparative physiology and biomimetics in metabolic and environmental health: what can we learn from extreme animal phenotypes? - Diabetologia This review explores the remarkable metabolic adaptations of species that thrive in extreme environments, providing insights into their resilience, flexibility and disease resistance. Species such as ...

Up front & free to read in our Feb issue #editorspicks: Comparative physiology and biomimetics in metabolic and environmental health: what can we learn from extreme animal phenotypes? doi.org/10.1007/s001...

2 0 0 0
Preview
Bridging the variant-to-function gap in type 2 diabetes: advances and challenges - Diabetologia Type 2 diabetes is a polygenic, heterogeneous disease affecting over 530 million individuals worldwide, a number projected to rise to 1.3 billion by 2050. Genome-wide association studies have identifi...

Up front & free to read in our Feb issue #editorspicks: Bridging the variant-to-function gap in type 2 diabetes: advances and challenges doi.org/10.1007/s001...

1 0 0 0
Post image

#editorspicks

@ponnsara.bsky.social spotlights the @rcphysicians.bsky.social Harveian Oration 2025 by Prof John Feehally

Nephrology 1950–2000: An exciting journey from birth to maturity ⏩

www.sciencedirect.co...

1 0 0 0
Post image

#editorspicks

Chiu et al reignite the debate on the utility of metabolic syndrome for cardiovascular risk prediction ↩️

@ponnsara.bsky.social

www.sciencedirect.co...

0 0 0 0
Post image

Ten reviews handpicked by the Choice editors from the January issue of Choice. These #EditorsPicks stand out for their excellence, timeliness, originality, or sheer reading pleasure.
ow.ly/pfcm50Y0lrW
#Academic #Publishing #BookReview

0 0 0 0

#editorspicks
Andrew Duncombe highlights new analysis showing NHS waiting lists would need to halve for 92% of patients to start elective treatment within 18 weeks.

Read the editorial 🔗: www.sciencedirect.co...
Read the article 🔗: www.sciencedirect.co...

0 0 1 0

Up front & free to read in our January issue #editorspicks: Improved wound healing by dual inhibition of miR‑146a‑5p and miR‑29a‑3p supports a network action of dysregulated miRNAs in diabetic skin link.springer.com/article/10.1...

3 0 0 0
Preview
Shared and distinct metabolomics profiles associated with microvascular complications in the Diabetes Prevention Program Outcomes Study - Diabetologia Aims/hypothesis The aim of this study was to identify shared and distinct metabolite profiles prospectively associated with nephropathy, retinopathy and neuropathy at 15 years’ follow-up among 1947 pa...

Up front & free to read in our January issue #editorspicks: Shared and distinct metabolomics profiles associated with microvascular complications in the Diabetes Prevention Program Outcomes Study doi.org/10.1007/s001...

2 0 0 0
Preview
Persistent C-peptide secretion is associated with favourable CGM metrics in adults with type 1 diabetes - Diabetologia Aims/hypothesis Residual endogenous insulin secretion, reflected by measurable C-peptide, has been linked to improved glycaemic management in type 1 diabetes. We aimed to assess the relationship betwe...

Up front & free to read in our January issue #editorspicks: Persistent C‑peptide secretion is associated with favourable CGM metrics in adults with type 1 diabetes doi.org/10.1007/s001...

3 1 0 0

Up front in @diabetologiajnl.bsky.social January issue #editorspicks #DiabetesResearch

1 0 0 0

Up front in @diabetologiajnl.bsky.social January issue #editorspicks #DiabetesResearch

1 0 0 0
Preview
Pharmacological therapies for type 2 diabetes: future approaches - Diabetologia Despite the availability of at least nine differently acting classes of glucose-lowering agents, many people with type 2 diabetes do not achieve or maintain sufficiently tight glycaemic control to avo...

Up front & free to read in our January issue #editorspicks: Pharmacological therapies for type 2 diabetes: future approaches doi.org/10.1007/s001...

2 0 0 1